Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 27.

Kostron, Arthur; Friess, Martina; Inci, Ilhan; Hillinger, Sven; Schneiter, Didier; Gelpke, Hans; Stahel, Rolf; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2017). Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients†. Interactive Cardiovascular and Thoracic Surgery, 24(5):740-746.

Parrotta, Rossella; Okonska, Agata; Ronner, Manuel; Weder, Walter; Stahel, Rolf; Penengo, Lorenza; Felley-Bosco, Emanuela (2017). A novel BRCA1-associated protein-1 isoform affects response of mesothelioma cells to drugs impairing BRCA1-mediated DNA repair. Journal of Thoracic Oncology, 12(8):1309-1319.

Gachechiladze, Mariam; Škarda, Josef; Kolek, Vítězslav; Grygárková, Ivona; Langová, Kateřina; Bouchal, Jan; Kolář, Zdeněk; Baty, Florent; Stahel, Rolf; Weder, Walter; Soltermann, Alex; Joerger, Markus (2017). Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer, 105:31-38.

Kostron, Arthur; Friess, Martina; Inci, Ilhan; Hillinger, Sven; Schneiter, Didier; Gelpke, Hans; Stahel, Rolf; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2017). Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients. Interactive Cardiovascular and Thoracic Surgery, 24(5):740-746.

Kroeze, Stephanie G C; Fritz, Corinna; Hoyer, Morten; Lo, Simon S; Ricardi, Umberto; Sahgal, Arjun; Stahel, Rolf; Stupp, Roger; Guckenberger, Matthias (2016). Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review. Cancer Treatment Reviews, 53:25-37.

Meerang, Mayura; Bérard, Karima; Friess, Martina; Bitanihirwe, Byron K Y; Soltermann, Alex; Vrugt, Bart; Felley-Bosco, Emanuela; Bueno, Raphael; Richards, William G; Seifert, Burkhardt; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2016). Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma. Molecular Oncology, 10(8):1255-1265.

Riesterer, Oliver; Weder, Walter; Stahel, Rolf (2016). Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power? - Authors' reply. Lancet Oncology, 17(2):e44-e45.

Morgan, Gilberto; Lambertini, Matteo; Kourie, Hampig Raphael; Amaral, Teresa; Argiles, Guillem; Banerjee, Susana; Cardone, Claudia; Corral, Jesus; De Mattos-Arruda, Letticia; Öztürk, Akif; Petrova, Mila; Poulsen, Laurids; Strijbos, Michiel; Tyulyandina, Alexandra; Vidra, Radu; Califano, Raffaele; de Azambuja, Evandro; Garrido Lopez, Pilar; Guarneri, Valentina; Reck, Martin; Moiseyenko, Vladimir; Martinelli, Erika; Douillard, Jean-Yves; Stahel, Rolf; Voest, Emile; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo; Cervantes, Andrés; Eggermont, Alexander M M; et al (2016). Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open, 1:e000107.

Kostron, Arthur; Friess, Martina; Crameri, Ornella; Inci, Ilhan; Schneiter, Didier; Hillinger, Sven; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2016). Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma†. European Journal of Cardio-Thoracic Surgery, 49(5):1516-1523.

Frischknecht, Lukas; Meerang, Mayura; Soltermann, Alex; Stahel, Rolf; Moch, Holger; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2015). Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery. Journal of Thoracic and Cardiovascular Surgery, 149(6):1539-1547.e1.

Thies, Svenja; Friess, Martina; Frischknecht, Lukas; Korol, Dimitri; Felley-Bosco, Emanuela; Stahel, Rolf; Vrugt, Bart; Weder, Walter; Opitz, Isabelle; Soltermann, Alex (2015). Expression of the stem cell factor nestin in malignant pleural mesothelioma is associated with poor prognosis. PLoS ONE, 10(9):e0139312.

Frauenfelder, Thomas; Kestenholz, Peter; Hunziker, Roger; Nguyen, Thi Dan Linh; Fries, Martina; Veit-Haibach, Patrick; Husmann, Lars; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2015). Use of Computed Tomography and Positron Emission Tomography/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma. Journal of Computer Assisted Tomography, 39(2):160-165.

Felley-Bosco, Emanuela; Stahel, Rolf (2014). Hippo/YAP pathway for targeted therapy. Translational Lung Cancer Research, 3(2):75-83.

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

Franzen, Daniel; Diebold, Matthias; Soltermann, Alex; Schneiter, Didier; Kestenholz, Peter; Stahel, Rolf; Weder, Walter; Kohler, Malcolm (2014). Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort study. BMC Pulmonary Medicine, 14:138.

Stahel, Rolf; Peters, Solange; Baas, Paul; Brambilla, Elisabeth; Cappuzzo, Federico; De Ruysscher, Dirk; Eberhardt, Wilfried Ernst Erich; Felip, Enriqueta; Fennell, Dean; Marchetti, Antonio; Paz-Ares, Luis; Adjei, Alex A (2013). Strategies for improving outcomes in NSCLC: a look to the future. Lung Cancer, 82(3):375-382.

Peters, Solange; Taron, Miquel; Bubendorf, Lukas; Blackhall, Fiona; Stahel, Rolf (2013). Treatment and detection of ALK-rearranged NSCLC. Lung Cancer, 81(2):145-154.

Lee, James A; Bubendorf, Lukas; Stahel, Rolf; Peters, Solange (2013). Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. Expert Review of Anticancer Therapy, 13(5):625-36.

Cerciello, Ferdinando; Choi, Meena; Nicastri, Annalisa; Bausch-Fluck, Damaris; Ziegler, Annemarie; Vitek, Olga; Felley-Bosco, Emanuela; Stahel, Rolf; Aebersold, Ruedi; Wollscheid, Bernd (2013). Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clinical Proteomics, 10:16.

Buchinger, Katharina; Stahel, Rolf; Niggemeier, Verena; Gubler, Christoph; Franzen, Daniel (2013). Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma. Lung Cancer, 80(3):347-349.

Samaras, Panagiotis; Zardavas, Dimitrios; Petrausch, Ulf; Buset, Elefteri M; Haile, Sarah R; Honegger, Hanspeter; Siciliano, Raffaele D; Schanz, Urs; Mischo, Axel; Schäfer, Niklaus G; Taverna, Christian; Knuth, Alexander; Stahel, Rolf; Renner, Christoph; Stenner-Liewen, Frank (2013). Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation. Swiss Medical Weekly, 143:w13791.

Schuberth, Petra C; Hagedorn, Christian; Jensen, Shawn M; Gulati, Pratiksha; van den Broek, Maries; Mischo, Axel; Soltermann, Alex; Jüngel, Astrid; Marroquin Belaunzaran, Osiris; Stahel, Rolf; Renner, Christoph; Petrausch, Ulf (2013). Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. Journal of Translational Medicine, 11:187.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

Collaud, Stéphane; Stahel, Rolf; Inci, Ilhan; Hillinger, Sven; Schneiter, Didier; Kestenholz, Peter; Weder, Walter (2012). Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. Lung Cancer, 78(3):234-238.

Stahel, Rolf (2012). Biomarker testing in non-small cell lung cancer: to move forward with quality. Clinical and Translational Oncology, 14(5):321-322.

von Boehmer, Lotta; Draenert, Alice; Jungraithmayr, Wolfgang; Inci, Ilhan; Niklaus, Schäfer; Boehler, Annette; Hofer, Markus; Stahel, Rolf; Soltermann, Alex; van den Broek, Maries; Weder, Walter; Knuth, Alexander (2012). Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer, 76(1):118-122.

Gridelli, Cesare; de Marinis, Filippo; Di Maio, Massimo; Ardizzoni, Andrea; Belani, Chandra P; Cappuzzo, Federico; Ciardiello, Fortunato; Fidias, Panagiotis; Paz-Ares, Luis; Perrone, Francesco; Pirker, Robert; De Petris, Luigi; Stahel, Rolf (2012). Maintenance treatment of advanced non-small-cell lung cancer: Results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Lung Cancer, 76(3):269-279.

This list was generated on Mon Dec 18 02:22:14 2017 CET.